Preventing Addiction Related Suicide (PARS) - Controlled Trial of Secondary Suicide Prevention

预防成瘾相关自杀 (PARS) - 二级自杀预防对照试验

• 批准号: 9926359
• 负责人: KATHERINE ANNE COMTOIS
• 金额: $ 0.85万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-15 至 2021-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9926359
• 关键词: Address; Administrator; Adult; Alcohol or Other Drugs use; Attitude; Behavior Therapy; Behavioral; Belief; Caring; Client; Clinic; Communities; Country; Data; Development; Dose; Drug abuse; Effectiveness; Enrollment; Evidence based practice; Family; Feeling suicidal; Friends; Goals; Group Therapy; Guidelines; Hour; Individual; Institutes; Intoxication; Knowledge; Mediating; Modality; National Institute of Drug Abuse; Outcome; Participant; Pharmaceutical Preparations; Population; Positioning Attribute; Prevention program; Prevention strategy; Professional counselor; Protocols documentation; Publishing; Randomized; Relapse; Reporting; Research; Research Personnel; Sampling; Substance Use Disorder; Suicide; Suicide attempt; Suicide prevention; Testing; Time; United States Substance Abuse and Mental Health Services Administration; Washington; addiction; alcohol abuse therapy; alcohol use disorder; base; community setting; compare effectiveness; design; effectiveness trial; follow up assessment; follow-up; help-seeking behavior; high risk; high risk population; improved; improved outcome; innovation; model design; multiple drug use; novel; outpatient programs; post intervention; prevent; programs; prospective; psychoeducational; public health relevance; selective prevention; skills; suicidal; suicidal behavior; suicidal risk; treatment as usual; treatment group; treatment site

Project Abstract/Summary Studies consistently show suicide and suicidal behaviors are highly related to substance use disorders (SUDs). Recent reviews find that the risk of suicide is 10-17 times higher for people using multiple drugs, injecting drugs, and for alcohol use disorders. Utilizing clearly established Stage I guidelines for developing and adapting behavioral interventions, as well as information included in a SAMHSA Treatment Improvement Protocol (TIP50) on suicide and addiction, the current Investigators developed the Preventing Addiction Related Suicide (PARS) program by integrating the content of empirically-supported secondary suicide prevention programs. PARS is a psychoeducational program taught as a single 3 hour module integrated into a standard group therapy-oriented Intensive Outpatient Program (IOP), the most common form of community drug abuse treatment.9 PARS was conceptualized and developed with a team of community treatment leaders who advised on its scope, duration, and approach. Community partners reviewed early drafts and all pilot testing was conducted in community treatment settings. Pilot testing of PARS demonstrated significant post- intervention increases in client knowledge of suicide and decreases in maladaptive attitudes toward suicide; both were maintained at 1-month follow-up. The likelihood of positive help seeking to prevent suicide for themselves as well as for a friend and for family all doubled for the month after the program compared to the month before. Given these promising Stage I results in Stage III settings, we propose a fully-powered Stage III effectiveness trial of PARS compared to Treatment-As-Usual (TAU) using a randomized stepped wedge design with 900 clients in 15 community addiction treatment sites in Washington State to replicate the pilot findings and evaluate how the mechanisms of improving accurate information and attitudes about suicide promote help-seeking. This proposal is innovative in its topic and development in community settings as well as its use of a stepped wedge design. Community treatment agencies, by integrating PARS into their IOP group treatment, are in a unique position to act as key players in the national suicide prevention strategy by providing accurate suicide prevention information, improving attitudes toward suicide, and increasing help- seeking skills to one of the most high-risk suicidal populations in the country.

项目摘要/摘要 研究一致地表明，自杀和自杀行为与药物使用障碍（SUD）高度相关。 最近的评论发现，使用多种药物的人自杀的风险高10-17倍 毒品和饮酒障碍。利用明确建立的I阶段的指南来制定和 适应行为干预措施以及SAMHSA治疗改进中的信息 关于自杀和成瘾的协议（提示50），当前的研究人员开发了预防成瘾 相关自杀（PARS）计划通过整合经验支持的次要自杀的内容 预防计划。 PARS是一项教授的心理教育计划，该计划将一个3小时的模块集成到 标准的小组治疗培训强化门诊计划（IOP），这是最常见的社区形式 毒品滥用治疗。9PARS是由社区治疗领袖团队进行概念化和开发的 他建议其范围，持续时间和方法。社区合作伙伴审查了早期草案和所有飞行员 在社区治疗环境中进行了测试。 PARS的试点测试显示出明显的后 干预措施增加了对自杀知识的知识，并减少了对自杀的不良态度； 两者都保持在1个月的随访中。寻求预防自杀的积极帮助的可能性 与一个朋友和家人一起，该计划后的一个月都翻了一番 一个月。鉴于这些有希望的阶段I在第三阶段设置中导致了III阶段的III期。 与使用随机阶梯楔相比，PAR的有效性试验与治疗 - 惯常（TAU）相比 华盛顿州的15个社区成瘾治疗网站的900个客户的设计，以复制飞行员 调查结果并评估如何改善对自杀的准确信息和态度的机制 促进寻求帮助。该建议在社区环境中的主题和发展方面具有创新性 作为使用阶梯楔设计的使用。通过将PAR集成到IOP中，社区治疗机构 小组治疗处于独特的位置，可以作为国家预防自杀策略的关键参与者 提供准确的自杀预防信息，提高对自杀的态度，并增加帮助 - 为该国最高风险的自杀人口之一寻求技能。